Síndrome metabólico e inflamación

  1. Alfonso Soto González 1
  2. Diego Bellido Guerrero 1
  3. Manuela Buño Soto 1
  4. Sonia Pértega Díaz 2
  5. Miguel Martínez del Olmo 3
  6. Ovidio Vidal 1
  1. 1 Servicio de Endocrinología y Nutrición. Hospital Juan Canalejo. A Coruña
  2. 2 Unidad de Epidemiología Clínica y Estadística. Hospital Juan Canalejo. A Coruña
  3. 3 Hospital Mexoeiro. Vigo. Pontevedra
Revista:
Clínica e investigación en arteriosclerosis

ISSN: 0214-9168 1578-1879

Ano de publicación: 2006

Volume: 18

Número: 3

Páxinas: 89-95

Tipo: Artigo

Outras publicacións en: Clínica e investigación en arteriosclerosis

Resumo

Introduction Patients with metabolic syndrome (MS) have an increased risk to have atherosclerosis and cardiovascular disease. Inflammation plays a crucial role in the atherosclerosis process. Some studies, even few, have shown the relationship between high levels of ferritin, with each component of the MS. Material and methods We studied 598 patients with overweight or obesity. We evaluated: the body composition and analytical parameters: glucose, cholesterol, triglycerides, high-density cholesterol and ferritin. Insulin resistance (IR) was defined by HOMA method. ATP III criteria were used to define MS. Results Higher levels of triglycerides have significant more elevated levels of ferritin (124.6 ng/ml versus 65.0 ng/ml; p = .001) or glucose (105.9 ng/ml versus 78.6 ng/ml; p = .023). The number of components of the MS increases with the values of ferritin. Patients with IR have higher values of ferritin (119.27 ng/ml versus 79.05 ng/ml; p = .001), with an area under the ROC curve of 0.678. Conclusions An Inflammatory parameter as ferritin could be useful and a precocious marker to evaluate chronic subclinic inflammatory process in daily medical practice.